Efficacy and safety of saffron as adjunctive therapy in adults with attention-deficit/hyperactivity disorder: A randomized, double-blind, placebo-controlled clinical trial

Post time 2026-7-24 02:12:46

journal：Advances in Integrative Medicine

Authors：Benyamin Pazoki; Nadia Zandi; Zeinab Assaf; Hossein Sanjari Moghaddam; Arefeh Zeinoddini; Mohammad Reza Mohammadi; Shahin Akhondzadeh

Published date：2022-3-

DOI：10.1016/j.aimed.2022.01.002

PDF link：https://www.sciencedirect.com/sc ... 212958822000027/pdf

Article link：https://doi.org/10.1016/j.aimed.2022.01.002

Article Source：Elsevier BV。

Remark：

Post time 2026-7-24 02:12:47

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] Efficacy and safety of saffron as adjunctive therapy in adults with attention-deficit/hyperactivity disorder: A randomized, double-blind, placebo-controlled clinical trial

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Efficacy and safety of saffron as adjunctive therapy in adults with attention-deficit/hyperactivity disorder: A randomized, double-blind, placebo-controlled clinical trial Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Efficacy and safety of saffron as adjunctive therapy in adults with attention-deficit/hyperactivity disorder: A randomized, double-blind, placebo-controlled clinical trial